Mediwound Ltd. balance sheet
At the end of fiscal 2025, Mediwound Ltd. had total assets of $86.3m, total liabilities of $42.6m and shareholders' equity of $43.6m. It held $4.8m in cash against $0 of debt: net cash of $4.8m.
Balance sheet
| Fiscal year | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 43 | 29 | 36 | 7 | 7 | 17 | 11 | 34 | 12 | 9 | 5 |
| Inventory | — | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 3 | 3 | 4 |
| Total current assets | — | 34 | 42 | 33 | 36 | 26 | 15 | 46 | 50 | 52 | 60 |
| Total assets | — | 36 | 44 | 35 | 41 | 31 | 20 | 50 | 66 | 73 | 86 |
| Total current liabilities | — | 5 | 5 | 5 | 10 | 8 | 11 | 12 | 18 | 27 | 26 |
| Total debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total liabilities | — | — | — | — | — | 24 | 24 | 39 | 35 | 42 | 43 |
| Shareholders' equity | 23 | 8 | 9 | 9 | 15 | 7 | −5 | 11 | 32 | 31 | 44 |
| Net debt (negative = net cash) | −43 | −29 | −36 | −7 | −7 | −17 | −11 | −34 | −12 | −9 | −5 |
| Shares outstanding | — | — | — | — | — | — | 4m | — | 9m | 11m | 13m |
Compare with peers
- Proqr Therapeutics N.V. balance sheet
- Cytomx Therapeutics, Inc. balance sheet
- Celularity Inc balance sheet
- Scynexis Inc balance sheet
- Keros Therapeutics, Inc. balance sheet
Head to head: MDWD vs PRQRCTMX vs MDWDCELU vs MDWD
More: Biotechnology stocks compared, Health Care sector, rankings of US companies